As expected, the epithelial CCM-induced increase TCF/LEF luciferase activity was abolished upon treatment of eMSCs with LGR5-siRNA (n = 8, P < 0.05, Fig. 3e). The gene discussed is LGR5; the disease is cerebral cavernous malformation.